Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27760872 | 0.84 | — | — | |
| Water SCHEMBL27166984 | 0.84 | TSHR (0.30) | — | |
| Acrylonitrile SCHEMBL28882188 | 0.82 | — | — | |
| SCHEMBL29133592 | 0.81 | TSHR (0.32) | — | |
| SCHEMBL2578 | 0.81 | — | — | |
| SCHEMBL28219780 | 0.78 | — | — | |
| Fluoride SCHEMBL15259547 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL11735071 | 0.78 | — | — | |
| SCHEMBL28176518 | 0.78 | — | — | |
| SCHEMBL30336744 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232117-B | Substituted isoxazole pyrimidine amine compound, preparation method and application thereof | 沈阳中化农药化工研发有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-117800973-A | Salts of PI3K inhibitors and methods of making the same | 因赛特控股公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117777139-A | Salts of PI3K inhibitors and methods of making the same | 因赛特控股公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117736209-A | Salts of PI3K inhibitors and methods of making the same | 因赛特控股公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117280504-A | Alkali metal galvanic cell with geminal dinitrile additive | 利特罗尼克电池技术有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-110964037-B | Pyrimidine-fused ring-containing compound and preparation method and application thereof | 沈阳中化农药化工研发有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115232117-A | Substituted isoxazole pyrimidinamine compound and preparation method and application thereof | 沈阳中化农药化工研发有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-108069984-B | Substituted five-membered heterocyclic compound containing pyrimido ring and preparation method and application thereof | 沈阳中化农药化工研发有限公司 | 2021-02-05 | — | — | CN | disclosed |
| CN-108069973-B | Substituted six-membered heterocyclic compound containing pyrimido ring and preparation method and application thereof | 沈阳中化农药化工研发有限公司 | 2020-08-11 | — | — | CN | disclosed |
| CN-110964037-A | Pyrimidine-fused ring-containing compound and preparation method and application thereof | 沈阳中化农药化工研发有限公司 | 2020-04-07 | — | — | CN | disclosed |
| US-7745020-B2 | Metallic compound and organic electroluminescence device comprising the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-06-29 | — | — | US | disclosed |
| US-7666869-B2 | to provide an aliphatic nitrogen-containing 5-membered ring compound represented by the formula [I]:** Image-1wherein symbols in the formula have the following meanings;A: CH2 or S , antidiabetic agents | MITSUBISHI TANABE PHARMA CORP. (JP) | 2010-02-23 | — | — | US | disclosed |
| EP-1323710-B1 | NITROGENOUS FIVE-MEMBERED RING COMPOUNDS | MITSUBISHI TANABE PHARMA CORP (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-20080193795-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-08-14 | — | — | US | disclosed |
| US-20080153821-A1 | Nitrogen-containing 5-membered ring compound | TANABE SEIYAKU CO., LTD. | 2008-06-26 | — | — | US | disclosed |
| WO-2007078185-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, HANYANG UNIVERSITY (KR) | 2007-07-12 | — | — | WO | disclosed |
| US-7138397-B2 | Nitrogenous 5-membered ring compounds | TANABE SEIYAKU CO., LTD. (JP) | 2006-11-21 | — | — | US | disclosed |
| CN-1633436-A | Pyrrolopyrimidine derivatives | TEIJIN LTD (JP) | 2005-06-29 | — | — | CN | disclosed |
| US-20050054678-A1 | Nitrogenous five-membered ring compounds | TANABE SEIYAKU CO., LTD. (JP) | 2005-03-10 | — | — | US | disclosed |
| EP-1323710-A1 | NITROGENOUS FIVE-MEMBERED RING COMPOUNDS | Tanabe Seiyaku Co., Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054678-A1 | Nitrogenous five-membered ring compounds | ALK, NPR1, SCO2 | ALDH1A1 2658/4885CASP1 2934/4885 |
| US-20080193795-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | PRMT5, CHRM5, PRMT6 | ALDH1A1 1810/4885CASP1 3120/4885 |
| US-20080153821-A1 | Nitrogen-containing 5-membered ring compound | ALK, SCO2, NPR1 | ALDH1A1 2491/4885CASP1 2822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.